Top dermatology news: Private equity debate, psoriasis therapy costs, more

Suzanne Bruce, MD
Suzanne Bruce

In the most popular Healio Dermatology story last week, Suzanne Bruce, MD, presented findings at the American Society for Dermatologic Surgery annual meeting from her research weighing the positives and negatives of private equity to help her decide how to transition her dermatology practice to allow more time with her family.

In a study assessing the cost of psoriasis treatment, tildrakizumab may be more cost-effective, according to research from Academy of Managed Care Pharmacy Nexus.

Continue reading for the top five most popular headlines last week.

 

Dermatologist dispels negative concerns about private equity

“After weighing the pros and cons, I sold to a private equity-backed group,” said Bruce, founder and president of Suzanne Bruce and Associates in Houston. “It is led by dermatologists with a strong clinical and business background. The group’s culture and medical practice philosophy align with us, which make it the right fit.” Read more.

 

Ilumya may reduce overall psoriasis treatment costs

Ilumya is among the most cost-effective first-line therapies for treating psoriasis, according to research presented by Justin Carrico, MD, of RTI Health Solutions, and colleagues at Academy of Managed Care Pharmacy Nexus. Read more.

 

Updates on medical innovations in aesthetics: Hair growth is holy grail

NEWPORT BEACH, Calif. — The unmet needs in the medical aesthetics market currently reside in hair growth, skin tightening and texture, and acne device-based technologies, according to researchers at a session on medical innovation in aesthetics. Read more.

 

Steering committee develops evidence-based consensus on cSCC staging, workup, treatment

CHICAGO — In patients with advanced cutaneous squamous cell carcinoma, a multidisciplinary discussion on treatment options should include oncologists, radiation oncologists and the primary care physician in weighing risks and benefits to various approaches, according to Todd Schlesinger, MD, FAAD, FASMS, medical director at Dermatology and Laser Center of Charleston. Read more.

 

Leadership accountability may help decrease physician burnout

CHICAGO — For university leadership, quantifying the bottom line in revenue loss due to physician burnout helps instill the importance of faculty wellness programs, Anita Blanchard, MD, associate dean for graduate medical education at University of Chicago, said during the American Society for Dermatologic Surgery annual meeting. Read more.

Suzanne Bruce, MD
Suzanne Bruce

In the most popular Healio Dermatology story last week, Suzanne Bruce, MD, presented findings at the American Society for Dermatologic Surgery annual meeting from her research weighing the positives and negatives of private equity to help her decide how to transition her dermatology practice to allow more time with her family.

In a study assessing the cost of psoriasis treatment, tildrakizumab may be more cost-effective, according to research from Academy of Managed Care Pharmacy Nexus.

Continue reading for the top five most popular headlines last week.

 

Dermatologist dispels negative concerns about private equity

“After weighing the pros and cons, I sold to a private equity-backed group,” said Bruce, founder and president of Suzanne Bruce and Associates in Houston. “It is led by dermatologists with a strong clinical and business background. The group’s culture and medical practice philosophy align with us, which make it the right fit.” Read more.

 

Ilumya may reduce overall psoriasis treatment costs

Ilumya is among the most cost-effective first-line therapies for treating psoriasis, according to research presented by Justin Carrico, MD, of RTI Health Solutions, and colleagues at Academy of Managed Care Pharmacy Nexus. Read more.

 

Updates on medical innovations in aesthetics: Hair growth is holy grail

NEWPORT BEACH, Calif. — The unmet needs in the medical aesthetics market currently reside in hair growth, skin tightening and texture, and acne device-based technologies, according to researchers at a session on medical innovation in aesthetics. Read more.

 

Steering committee develops evidence-based consensus on cSCC staging, workup, treatment

CHICAGO — In patients with advanced cutaneous squamous cell carcinoma, a multidisciplinary discussion on treatment options should include oncologists, radiation oncologists and the primary care physician in weighing risks and benefits to various approaches, according to Todd Schlesinger, MD, FAAD, FASMS, medical director at Dermatology and Laser Center of Charleston. Read more.

 

Leadership accountability may help decrease physician burnout

CHICAGO — For university leadership, quantifying the bottom line in revenue loss due to physician burnout helps instill the importance of faculty wellness programs, Anita Blanchard, MD, associate dean for graduate medical education at University of Chicago, said during the American Society for Dermatologic Surgery annual meeting. Read more.